Newly appointed Health and Human Services Secretary Alex Azar has been charged with bringing down drug prices. He's a fan of demanding transparency from drug companies, but many states have already done that, and the impact on pricing is unclear.
from Forbes Real Time https://www.forbes.com/sites/arleneweintraub/2018/03/30/the-call-for-drug-price-transparency-is-growing-louder-but-will-it-matter/
via IFTTT
No comments:
Post a Comment